LKFTLakefront Biotherapeutics NV
$29.51-11% 1Y
$29.51
$26.0752 weeks$37.62
LKFT as reported
- Operating margin
- −39%
Operating margin · trailing twelve months to Q2 2021
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Operating margin | −39% | n/a | Q2 2021 |
| Net margin | −19% | n/a | Q2 2021 |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.
Lakefront Biotherapeutics NV (LKFT) · Revenue and profitRevenue and profitLakefront Biotherapeutics NV (LKFT)
RevenueNet incomeTrailing twelve months
Powered byryufin.com
